抑制剂简介
抑制剂是一类能够降低或阻止生物体内的酶活性、受体的活性或是细胞内特定反应过程的小分子化合物。它们在有机化学、化学化工和生物医药领域中有着广泛的应用,尤其是在药物研发方面。
分类与作用机制
应用领域
总结
抑制剂的研究和发展对于理解生命过程至关重要,并在药物开发、基础科学研究等多个领域发挥着重要作用。随着技术的进步,新的抑制剂不断被发现和开发出来,为医学治疗提供了更多的可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
3-氨基-6-[4-(甲基磺酰基)苯基]-N-苯基-2-吡嗪甲酰胺 | VE-821 | 1232410-49-9 | C18H16N4O3S |
|
3-氨基-6-[4-(4-甲基哌嗪-1-基)磺酰基苯基]-n-吡啶-3-基吡嗪-2-羧酰胺 | AZD2858 | 486424-20-8 | C21H23N7O3S |
|
3-氨基-5-氯-4-羟基苯磺酸 | 1-hydroxy-2-amino-6-chlorobenzene-4-sulfonic acid | 5857-94-3 | C6H6ClNO4S |
|
3-氨基-4-环己基氨基苯甲酸乙酯 | ferrostatin-1 | 347174-05-4 | C15H22N2O2 |
|
3-氟-5-[3-(5-氟-2-吡啶基)-1,2,4-恶二唑-5-基]苄腈 | [3H]-AZD 9272 | 327056-26-8 | C14H6F2N4O |
|
3-吲哚乙酰胺 | 3-indolylacetamide | 879-37-8 | C10H10N2O |
|
3-去氮腺嘌呤A | 3-deazaneplanocin A hydrochloride | 120964-45-6 | C12H14N4O3*ClH |
|
3-{4-[2-({6-氨基-9-[(2R,3R,4S,5S)-5-(乙基氨基甲酰)-3,4-二羟基四氢-2-呋喃基]-9H-嘌呤-2-基}氨基)乙基]苯基}丙酸盐酸盐(1:1) | 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine hydrochloride | 124431-80-7 | C23H29N7O6*ClH |
|
3-[[[3-[(二甲基氨基)甲基]苯基]氨基]苯基亚甲基]-2,3-二氢-2-氧代-1H-吲哚-6-甲酰胺 | (Z)-3-(((3-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxamide | 1094614-84-2 | C25H24N4O2 |
|
3-[[6-(3-氨基苯基)-7H-吡咯并[2,3-d]嘧啶-4-基]氧基]苯酚 | TWS 119 | 601514-19-6 | C18H14N4O2 |
|
3-[[4-[6-溴-2-[4-(4-甲基哌嗪-1-基) 苯基]-3H-咪唑并[4,5-b]吡啶-7-基]哌嗪-1-基]甲基]-5-甲基异恶唑 | CCT137690 | 1095382-05-0 | C26H31BrN8O |
|
3-[[2-(4-氟苯基)乙基]氨基]-1-甲基-4-(2-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮 | 3-[[2-(4-fluorophenyl)ethyl]amino]-1-methyl-4-(2-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione | 1129669-05-1 | C22H20FN3O2 |
|
3-[6-[[4-(三氟甲氧基)苯基]氨基]-4-嘧啶基]苯甲酰胺 | GNF-2 | 778270-11-4 | C18H13F3N4O2 |
|
3-[5-(2-氟苯基)-1,2,4-恶二唑-3-基]苯甲酸 | ataluren | 775304-57-9 | C15H9FN2O3 |
|
3-[3-[4-[(甲基氨基)甲基]苯基]-5-异恶唑基]-5-[4-[异丙磺酰基]苯基]-2-吡嗪胺 | VE822 | 1232416-25-9 | C24H25N5O3S |
|
3-[3-(吡啶-3-基)-1,2,4-恶二唑-5-基]苯甲腈 | 3-(3-(pyridine-3-yl)-1,2,4-oxadiazol-5-yl)benzonitrile | 913830-15-6 | C14H8N4O |
|
3-[2-(甲基氨基)乙基]-1H-吲哚-4-醇 4-(磷酸二氢酯) | baeocystin | 21420-58-6 | C11H15N2O4P |
|
3-[2-(Boc-氨基)乙基]氮杂丁烷盐酸盐 | tert-butyl 2-(azetidin-3-yl)ethylcarbamate hydrochloride | 1170905-43-7 | C10H20N2O2*ClH |
|
3-[1-[3-(二甲氨基)丙基]1H-吲哚-3-基]-4-(吲哚-3-基)1H-吡咯-2,5二酮 | bisindolylmaleimide I | 133052-90-1 | C25H24N4O2 |
|
3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮 | GO 6983 | 133053-19-7 | C26H26N4O3 |
|
3-[(二甲基氨基)甲基]-n-[2-[4-[(羟基氨基)羰基]苯氧基]乙基]-2-苯并呋喃羧酰胺 | abexinostat | 783355-60-2 | C21H23N3O5 |
|
3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺 | OSI-930 | 728033-96-3 | C22H16F3N3O2S |
|
3-[(3-氯-4-羟苯基)氨基]-4-(2-硝苯基)-1H-吡咯-2,5-二酮 | 3-[(3-chloro-4-hydroxyphenyl)amino]-4-(2-nitro-phenyl)-1H-pyrrole-2,5-dione | 264218-23-7 | C16H10ClN3O5 |
|
3-[(3-三氟甲基)苯基]-5-[(4-羧基苯基)亚甲基]-2-硫代-4-噻唑烷酮 | 4-[[4-oxo-2-sulfanylidene-3-[3-(trifluoromethyl)phenyl]-1,3-thiazolidin-5-ylidene]methyl]benzoic acid | 307510-92-5 | C18H10F3NO3S2 |
|
3-[(3,5-二甲基-1H-吡咯-2-基)亚甲基]-1,3-二氢-2H-吲哚-2-酮 | semaxanib | 194413-58-6 | C15H14N2O |
|
3-(甲基磺酰基)丙腈 | OLT1177 | 54863-37-5 | C4H7NO2S |
|
3-(二甲基氨基)-N-[3-[(4-羟基苯甲酰基)氨基]-4-甲基苯基]苯甲酰胺 | ZM 336372 | 208260-29-1 | C23H23N3O3 |
|
3-(5-氟苯并呋喃-3-基)-4-(5-甲基-5H-[1,3]二噁唑并[4,5-f]吲哚-7-基)-1H-吡咯-2,5-二酮 | 9-ING-41 | 1034895-42-5 | C22H13FN2O5 |
|
3-(4-氯-2-氟苄基)-2-甲基-N-(3-甲基-1H-吡唑-5-基)-8-(吗啉甲基)咪唑并[1,2-b]吡嗪-6-胺 | 3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholino-methyl)imidazo[1,2-b]pyridazin-6-amine | 1229236-86-5 | C23H25ClFN7O |
|
3-(4-((3-苯氧基苄基)氨基)苯基)丙酸 | 4-[[(3-phenoxyphenyl)methyl]amino]benzenepropranoic acid | 885101-89-3 | C22H21NO3 |
|
3-(3,5-二溴-4-羟基苯基)-N-[(4-苯氧基苯基)甲基]-1,2,4-恶二唑-5-甲酰胺 | IOWH-032 | 1191252-49-9 | C22H15Br2N3O4 |
|
3-(3,5-二溴-4-羟基苯亚甲基)-5-碘-1,3-二氢吲哚-2-酮 | 3-(3,5-dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol-2-one | 220904-83-6 | C15H8Br2INO2 |
|
3-(3,5-二氯-4-羟基苯甲酰基)-1,1-二氧代-2,3-二氢-1,3-苯并噻唑 | dotinurad | 1285572-51-1 | C14H9Cl2NO4S |
|
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 | INK128 | 1224844-38-5 | C15H15N7O |
|
3-(2-吡啶基二硫基)丙酸N-羟基琥珀酰亚胺酯 | N-succinimydyl 3-(2-pyridyldithio)propionate | 68181-17-9 | C12H12N2O4S2 |
|
3-(2,4-二羟基-5-异丙基苯基)-4-(1-甲基吲哚-5-基)-5-羟基-4H-1,2,4-噻唑 | ganetespib | 888216-25-9 | C20H20N4O3 |
|
3-(2,4-二氯苯基)-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮 | SB-216763 | 280744-09-4 | C19H12Cl2N2O2 |
|
3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮 | (3-(2,4-dichloro-5-methoxyphenyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one) | 338967-87-6 | C15H10Cl2N2O2S |
|
3-(2,4-二氨基蝶呤-6-基)苯酚 | TG100713 | 925705-73-3 | C12H10N6O |
|
3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮 | sotrastaurin | 425637-18-9 | C25H22N6O2 |
|
3-(1-甲基-4-哌啶基)-1H-吲哚-5-醇 | 5-hydroxy-3-(1-methylpiperidin-4-yl)indole | 57477-39-1 | C14H18N2O |
|
3-(1-氰基-1-甲基乙基)-N-[3-[(3,4-二氢-3-甲基-4-氧代-6-喹唑啉基)氨基]-4-甲基苯基]苯甲酰胺 | AZ628 | 878739-06-1 | C27H25N5O2 |
|
3-(1,3-苯并二恶唑-5-基)-5-(3-溴苯基)-1H-吡唑 | 3-(benzo[d][1,3]dioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole | 882697-00-9 | C16H11BrN2O2 |
|
3,6-二溴吲哚-alpha-(1-哌嗪甲基)-9H-咔唑-9-乙醇双盐酸盐 | Bax Channel Blocker | 335165-68-9 | C19H23Br2Cl2N3O |
|
3,4-二氯-N-(1-甲基丁基)-苯甲酰胺 | NSC405020 | 7497-07-6 | C12H15Cl2NO |
|
3,4-二氢-2,2-二甲基-2H-萘并[1,2-B]吡喃-5,6-二酮 | 2,2-dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione | 4707-32-8 | C15H14O3 |
|
3,4-二氟-2-[(2-氟-4-碘苯基)氨基]-N-(2-羟基乙氧基)-5-[(3-氧代-[1,2]恶嗪-2-基)甲基]苯甲酰胺 | RO-4987655 | 874101-00-5 | C20H19F3IN3O5 |
|
3,3’-(2,4-二氨基-6,7-蝶啶二基)二苯酚 | TG100-115 | 677297-51-7 | C18H14N6O2 |
|
2H-四唑乙酸,5-[3-[4-(2-溴-5-氟苯氧基)-1-哌啶基]-5-异恶唑]- | 2-(5-{3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl}-2H-1,2,3,4-tetrazol-2-yl)acetic acid | 1030612-90-8 | C17H16BrFN6O4 |
|
2H-1,4-噻嗪-3(4H)-酮,2-羟基-4-(1-甲基乙基)- | N-((3S,5S)-1-(Benzo[d][1,3]dioxol-5-ylmethyl)-5-(piperazine-1-carbonyl)pyrrolidin-3-yl)-N-(3-methoxybenzyl)-3,3-dimethylbutanamide | 334998-36-6 | C31H42N4O5 |
|